SOAT1 and cancer: EXOSC5, recognized as a tumor suppressor, has been downregulated in various cancers, including renal cell carcinoma, and plays a critical role in signaling pathways like JAK-STAT, MAPK, and WNT, which are crucial for cancer progression [49].